Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Relyon Plasma GmbH currently manages 1 pending office action within the Medical Devices & Mechanical Engineering technology area. This matter is assigned to 1 distinct examiner, ANDREW J MENSH, and is being reviewed in 1 distinct art unit. The existence of 1 pending action suggests a highly targeted patent strategy for their plasma-related innovations.
ANDREW J MENSH is the busiest examiner for the company, handling the 1 pending matter. With only a single examiner and art unit involved, the prosecution is highly centralized. This relationship between the action and the examiner means the outcome depends on a single individual's assessment. The focus within 1 distinct art unit indicates that the technology is likely specialized within the Medical Devices & Mechanical Engineering sector. Having this single pending action simplifies the management of their current USPTO portfolio.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MENSH, ANDREW J | 1 | 64.5% | +19.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19009673 | DEVICE FOR THE MEDICAL TREATMENT OF HUMANS AND ANIMALS, AND APPLICATION DEVICE FOR SAME | MENSH, ANDREW J | — |
| Art Unit | Apps |
|---|---|
| 3781 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19009673 | DEVICE FOR THE MEDICAL TREATMENT OF HUMANS AND ANIMALS, AND APPLICATION DEVICE FOR SAME | MENSH, ANDREW J | 3781 | §103 | Non-Final OA | — | Pending | Jan 03, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialRelyon Plasma GmbH has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Andrew J Mensh has the most, with 1 of Relyon Plasma GmbH's pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
